Related Experiment Videos
Silent acute rejection during prolonged delayed graft function reduces kidney allograft survival
Fawad Qureshi1, Hamid Rabb, Bertram L Kasiske
1Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA.
Transplantation
|November 27, 2002
Summary
Silent acute rejection (AR) is frequent during delayed graft function (DGF) after kidney transplants. Protocol biopsies during DGF can identify silent AR, which significantly impacts long-term kidney allograft survival.
Area of Science:
- Nephrology
- Transplantation immunology
- Clinical research
Background:
- The impact of early, silent acute rejection (AR) and delayed graft function (DGF) on kidney allograft survival is debated.
- The utility of protocol biopsies in managing DGF remains unclear.
Purpose of the Study:
- To investigate the hypothesis that protocol biopsies during DGF reveal a high incidence of silent AR.
- To determine if silent AR adversely affects long-term kidney allograft survival.
Main Methods:
- Retrospective analysis of 410 kidney transplants.
- Routine protocol biopsies performed 7-10 days post-transplant for patients requiring dialysis.
- Cox proportional hazards analysis to assess the impact of silent AR during DGF on graft survival.
Main Results:
- The cumulative incidence of AR was 57.2% in patients with DGF undergoing protocol biopsy versus 15.1% without.
- Prolonged DGF significantly increased graft failure risk (HR 3.08).
- Silent AR detected by protocol biopsy carried a similar risk of graft failure as early AR in non-DGF patients (HR 2.91 vs. 2.95).
- After accounting for AR, the risk of graft failure from prolonged DGF was reduced (HR 1.76), indicating AR mediates much of the DGF risk.
Conclusions:
- Silent AR is a common finding during DGF in kidney transplant recipients.
- Prolonged DGF is linked to reduced graft survival, largely explained by the presence of silent AR.
- Protocol biopsies and treatment of silent AR during DGF are recommended in the absence of randomized trial data.